AI Weekly Malaysia

Back to items Summaries

Pancreatic cancer halted by virus injection in three patients

ID
48507
Status
summarized
Published
20 Nov 2026, 1:25 AM
Fetched
20 Nov 2026, 6:32 AM
Provider
Hacker News
Category
dev-community
Original URL
https://www.newscientist.com/article/2528235-pancreatic-cancer-halted-by-virus-injection-in-three-patients/
Source URL
https://hnrss.org/best

Summary

Score
2.0
Created
20 Nov 2026, 6:33 AM
Tags
Audience
developers

What happened

A cancer-killing virus injection stopped pancreatic tumours from growing in three patients in a US safety trial, with the first patient treated a year ago and all three still alive with clinically stable disease. The tumours were confined to the pancreas at treatment time — one was 7 centimetres across — and patients received only one-tenth of the intended dose, according to Masato Yamamoto at the University of Minnesota, who presented the results at the American Society of Gene and Cell Therapy meeting in Boston. Another 15 patients will now get higher doses to find the optimum level, and surgeon Kai Brown at Royal North Shore Hospital in Sydney cautioned that oncology is full of early signals that vanished in phase III testing.

Why it matters

Nothing here changes what a developer, founder, or AI builder ships this week — this is a phase I safety signal with n=3, reported at a conference, not a peer-reviewed efficacy result. The only concrete takeaway is calibration: 'halted' here means stable disease (no growth), not shrinkage, at 10% of the target dose, with 15 more patients still to be dosed. Treat the 304-point HN thread as interest in the topic, not evidence the result is practice-changing.

Discussion angle

Use it as a 2-minute media-literacy exercise: what's the difference between 'tumour halted', 'stable disease', and 'tumour shrunk', and why does dose-escalation with 15 more patients matter before anyone calls this a breakthrough?

Top